T

Tarsus Pharmaceuticals

Develops FDA-approved ophthalmic therapies

Manager 2 - Program Management, Late-Stage Development

Program ManagementConfirmed live in the last 24 hours
Full-timeIrvine, CA, USA

About the Job

Requirements

  • Minimum 8 years of product development experience in biotech or pharmaceutical settings, including at least 5 years in a project or program management role.
  • Experience managing drug development programs from pre-clinical through Phase III studies is essential.
  • A bachelor's degree in a biopharmaceutical-related field, such as biology, chemistry, or engineering, is required.
  • Working knowledge of the end-to-end drug development process, including GxP/ICH guidelines and health authority interactions, for late-stage programs.
  • Proficient use of IT and project management tools such as Outlook, Excel, PowerPoint, MS Project, Smartsheet, or similar tools.
  • Established track record of effective people management, problem solving, collaboration, cross-functional leadership, and communication.
  • Strong project/program management foundation.

Responsibilities

  • Partner with the Program Team Lead and Development Core Team to develop and execute cross-functional program strategy and integrated development plans for a late-stage program.
  • Establish and maintain functionally integrated program timelines spanning clinical, regulatory, CMC/manufacturing, quality, nonclinical, medical affairs, and commercial activities to enable accurate program analyses, identify critical path activities, and surface resource constraints.
  • Lead cross-functional planning and coordination for pivotal (Phase 3) trial execution, database lock, and topline readout activities.
  • Drive integrated regulatory submission planning and execution (e.g., NDA/BLA/MAA) in close partnership with Regulatory Affairs, ensuring alignment of cross-functional deliverables to support on-time, high-quality filings.
  • Support launch readiness planning by coordinating cross-functionally across clinical development, regulatory, medical affairs, commercial, and supply chain/manufacturing.
  • Identify and assess program risks; develop, track, and drive mitigation and contingency plans, including maintenance of a program risk register.
  • Lead scenario planning efforts to prepare teams for differing outcomes at key milestones, such as pivotal readouts, regulatory interactions, and launch.
  • Challenge assumptions and provide recommendations to improve program processes, decision-making, and outcomes.
  • Facilitate and document Development Core Team and sub-team meetings, cross-functional communications, and governance decisions, ensuring alignment with internal functional groups and leadership.
  • Support program budget and resource planning in partnership with Finance and functional leads, tracking spend against forecast and flagging variances.
  • Develop strong relationships with key functional stakeholders and their leadership across the organization to support execution of program goals.
  • Serve as a Program Management subject matter expert and resource for the broader organization, championing program management best practices and continuous improvement.
  • Demonstrate effective decision-making by identifying, analyzing, and resolving issues or challenges; navigating uncertainty; and implementing structured, outcome-oriented solutions.
  • Build relationships and networks, respect different points of view, cultivate discussion and debate, and put the team first.
  • Define mutual expectations, adapt to changing business needs, find solutions to obstacles, and take appropriate actions to meet obligations.
  • Some travel may be required, up to 10%.

Desired Qualifications

  • Direct experience supporting a drug development program through pivotal trials, regulatory submission, and launch readiness is strongly preferred.
  • An advanced degree is a plus.
  • PMP or PgMP certification is preferred but not required.

About the Company

Tarsus Pharmaceuticals

Develops FDA-approved ophthalmic therapies

Tarsus Pharmaceuticals develops and markets treatments for eye care and infectious diseases, including XDEMVY (lotilaner ophthalmic solution 0.25%), an FDA-approved eye drop for Demodex Blepharitis. The product is applied as a medicated eye drop to kill Demodex mites and relieve eyelid inflammation. The company differentiates itself with a focused ocular/infectious-disease portfolio, an FDA-approved therapy, and active partnerships to expand its research and reach. Its goal is to address unmet medical needs, grow its product lineup through commercialization, and pursue new indications in eye care and infectious diseases.

Company size
201-500
Company stage
IPO
Headquarters
Irvine, CA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Tarsus Pharmaceuticals

See more jobs